Background—A variety of transcatheter atrial septal defect (ASD) occluders are currently in
use around the world. Although for the most part effective, all of these devices lack features …

There has been a remarkable evolution of devices for transcatheter ASD and PFO closure
since the early 1980s [1••, 2]. As experience has been gained with a number of devices …

BACKGROUND: The HELEX septal occluder is a new transcatheter atrial septal defect
occlusion device. This study analyzes the data collected from the first US clinical trials with …

Objectives: Occlutech Figulla ASD Occluder (FSO) is an alternative device to Amplatzer
Septal Occluder (ASO) with some structural innovations including increased flexibility …

Catheter closure of atrial septal defects (ASDs) is an accepted procedure among pediatric
cardiologists. We report our early experience with the newest of these devices in clinical …

Objectives: This report describes the immediate, 1-, and 5-year follow-up results of the US
Food and Drug Administration Continued Access clinical trial of the GORE HELEX Septal …

Objectives: This study sought to compare the safety and efficacy of the HELEX septal
occluder (HSO) with surgical repair of atrial septal defect (ASD). Background: The HSO is a …

The Ceraflex atrial septal defect occluder is an alternative device to the Amplatzer septal
occluder with some structural innovations including flexible connection, increased flexibility …

Background: Percutaneous closure of secundum type atrial septal defect (ASD) and patent
foramen ovale (PFO) has gained widespread use in recent years. Herein, we evaluated the …

The results of transcatheter atrial septal defect (ASD) occlusion with 2 different devices
(Sideris adjustable buttoned device vs Amplatzer Septal Occluder) were compared in 2 …